introduction child born small gestational age sga exposed greater morbidity mortality neonatal period also shown low birth weight associated various pathology childhood later life pathology include growth pubertal neuro-cognitive disorder well metabolic syndrome cardiovascular event adult reason specific follow-up patient required health-related quality life hrqol reflects perception health physical emotional social well-being individual relevant outcome ass course different pathology efficacy treatment used generic instrument questionnaire available allow study hrqol across different pathology tool designed specific entity quality life assessment growth hormone deficiency adult measure qol-agdha used evaluate effect recombinant human growth hormone rhgh adult deficiency also specific tool evaluate hrqol child short stature applied study carried subject sga idiopathic short stature individual multiple pituitary deficit young adult sga patient generic tool used short form health survey sf-36 tno-azl adult quality life child health illness profile adolescent edition chip-ae proved reliable consistent pathology neuro-cognitive learning problem sga child highlighted several publication sga subject experience catch-up growth seem achieve better skill evidence intellectual performance sga without catch-up improves treatment rhgh general population sga adult achieve lower professional economic goal born adequate weight difference degree life satisfaction marital status hrqol measured sf-36 questionnaire sgas shown similar lower result obtained individual born adequate weight sga patient without catch growth study report better quality life rhgh treatment correlating height gain showing similar hrqol control population improving previous score present study carried sga patient without spontaneous catch growth treated rhgh according current guideline european medicine agency ema hrqol evaluated end follow-up comparing result published reference general population correlation analyzed hrqol result auxological parameter socioeconomic level patient method patient study design multicenter observational retrospective study including adult sga sample followed pediatric endocrinology unit four spanish tertiary hospital patient received treatment rhgh sga indication according ema guideline sga defined birth weight and/or birth length 2sd treatment indicated child height 2.5sd year old patient chronic disease hormonal deficit pituitary thyroid pancreatic adrenal gonadal severe postnatal sequela bone dysplasia genetic-malformative syndrome obese body mass index bmi p97 excluded patient incomplete neonatal parental height data patient poor adherence rhgh treatment also excluded cohort patient treated rhgh sga indication reached final height selected offered participate study wanted take part retrospective data perinatal family data auxologic data start treatment follow-up registered side effect collected medical record adult weight height measured face-to-face visit end treatment socioeconomic status also estimated quality life assessed anthropometric data questionnaire anthropometric data converted standard deviation spanish collaborative study growth response treatment rhgh evaluated year expressing height gain δsd initial height treatment efficacy assessed calculating δsd adult height compared initial height difference target genetic height socioeconomic level estimated using graffar test arranges patient different social class i–v according profession educational level income source housing neighborhood scale family occupies society obtained based sum score family highest stratum belong highest level well-being family relative poverty extreme critical poverty belong lowest stratum qol-aghda sf-36 questionnaire used ass hrqol qol-aghda simple self-administered questionnaire containing question yes/no answer take minute complete affirmative answer one point assigned point added give single index ranging higher score indicates worse hrqol sf-36 questionnaire internationally accredited instrument validated spanish language includes item grouped domain physical functioning item physical role item bodily pain item general health item vitality item social functioning item emotional role item mental health item score obtained domain transformed scale ranging worst best resulting scale turn grouped two summary measure physical health mental health result adding previous score corrected coefficient summary score compared percentile value general population sample additional item evolution health included summary measure separately assessed reflecting change health perception since previous year much better much worse survey reviewed analyzed observer statistical study normality study initially performed apply parametric non parametric test subsequently depending variable analyzed appropriate test applied considering statistical significance 0.05 confidence interval statistical treatment performed ibm spps statistic program window ethic approval prior study approval obtained different research ethic committee four participating hospital hospital universitarui arnau vilanova research ethic committee protocol v.2018 hip/ci v.7/2019 informed consent obtained patient access data medical record carry face-to-face visit adulthood result sample patient studied female table show data birth parent height one patient born multiple gestation seven preterm gestational age 30–36 week ninety percent suffered perinatal problem remaining reported mild anemia jaundice respiratory distress table data birth parental height patient born small gestational age without postnatal catch-up growth full size table rhgh treatment started age 7.6 3.0 year duration 7.1 2.8 year mean cumulated height gain first year 0.8 0.8 1.2 1.1 second year adult height 1.2 0.9 slightly lower target height 0.9 table side effect related treatment reported patient igf-1 value remained normal range time patient completed treatment final height premature discontinuation table change anthropometric parameter recombinant human growth hormone rhgh treatment adult height subject born small gestational age without catch-up growth full size table thirty-eight patient prepubertal treatment start tanner stage ii–iii treatment puberty started 12.1 1.2 year boy 10.6 1.3 year girl girl low predicted adult height predicted adult height difference respect target height treatment associated gnrh analogue gnrha 8.3 0.7 year old 125.1 2.3 bone age 0.3 year reaching final height 1.4 0.7 remaining woman reached final height 1.3 0.8 0.4 age menarche 14.1 1.0 year rhgh gnrha 13.0 1.2 year rhgh 0.15 group difference observed age end treatment bmi result quality life questionnaire age 21.2 2.8 year 6.5 2.8 year end treatment rhgh patient called measure height weight fill questionnaire according graffar test sample belonged group highest class group group iii group sf-36 questionnaire physical functioning physical role domain best score vitality mental health domain worst concerning summary measure better result found physical health mental health laying mean value population reference table 25th percentile patient physical health mental health male scored lower mean physical health mental health summary measure fig table overall result quality life questionnaire full size table figure physical health summary mental health summary full size image age patient questionnaire filled correlated positively physical health 0.280 0.04 physical role positively associated target height 0.371 0.005 age rhgh start 0.31 0.019 negatively correlated difference adult height sd—target height 0.27 0.044 adult weight 0.54 0.021 mean value declared evolution health status 2.7 0.9 mode frequent value indicating absence change one year health status evolution positively correlated age treatment start 0.29 0.046 negatively correlated duration 0.31 0.029 thus scoring worse treatment started later qol-aghda questionnaire patient scored mean indicating worse quality life exceeded showing lower sensitivity sf-36 qol-aghda score correlated target height sd—final height difference 0.28 0.04 sf-36 mental health score 0.42 0.04 physical functioning 0.41 0.04 physical role 0.34 0.02 emotional role 0.62 0.00 social function 0.27 0.01 vitality 0.42 0.007 mean sf-36 0.62 0.00 mental health summary 0.42 0.00 significant correlation general health 0.25 0.86 bodily pain physical health summary 0.11 0.46 table gnrha treatment impact quality life questionnaire result correlation hrqol score socioeconomic status found discussion mean 1.7 height gained patient start rhgh similar achieved series final height slightly lower target height puberty onset range reference population age menarche excluding patient treated gnrha one year later compared sga cohort treatment rhgh doe seem affect puberty timing sga although spontaneous catchup growth sga may associated pubertal advancement gnrha treatment affect hrqol questionnaire result described study hrqol previously studied sga adult heterogeneous result example irish cohort sga adult born single maternity hospital belfast difference sf-36 score found compared normal birth weight control conversely another cohort adult peg norway hrqol decrease mental emotional social domain sf-36 observed linked increase psychiatric pathology sga population without catch previously investigated using generic tool eq-5d sf-36 taaqol well specific one short stature qolissy currently specific instrument available sga adult without catch growth used sf-36 generic instrument qol-aghda designed adult growth hormone deficiency establish correlation sf-36 ass usefulness sga treated final height contrast sommer multicenter study show sga complete treatment rhgh score standard mean sf-36 25th percentile indicates moderate difference respect population physical health mental health summary measure author found lower score mental health emotional role social function domain higher prevalence psychiatric pathology sga pathology worsen adolescence adulthood however cohort better sf-36 mental health value associated older age time questionnaire filled year elapsed since end treatment could interpreted increasing resilience problem facing age worse score male patient together lower proportion sample suggest participation study voluntary could lead biased inclusion poorer perception health found correlation hrqol main target rhgh treatment adult height difference adult height genetic height physical role domain correlate difference adult weight correlate negatively mean sf-36 score physical role table neither physical role health evolution significant weight calculation mental health summary measure affected parameter low correlation adult height hrqol series surprising since patient reached height within normal limit hand discordance already described general population patient short stature different etiology effect rhgh deficient subject beyond increase height act directly perception health well-being patient time elapsed end treatment rule possible effect treatment hrqol outcome could attributed treatment discontinuation since known adolescent growth hormone deficiency ending treatment upon reaching final height effect hrqol neither detect significant correlation hrqol socioeconomic level possible confounding factor regarding qol-aghda significant correlation detected aspect related rhgh treatment age start dose adult height excluding difference target height final height qol-aghda result present negative correlation domain related mental health also physical function physical role domain sf-36 questionnaire concluded explore similar feature however qol-aghda easy complete ass specifically designed adult growth hormone deficiency identifies sga patient sample low hrqol showing lower sensitivity sf-36 however sf-36 doe investigate important aspect sleep cognitive function sexual activity addition neuro-cognitive psychiatric assessment would provide complete picture hrqol sga patient end follow-up transition adulthood inclusion study voluntary influence result know could positive negative way maybe patient problem participated patient without problem way around addition although sample size large study one important carry order detect quality life problem patient may present looking future would interesting carry prospective study evaluate quality life patient beginning treatment annually see evolves conclusion adult sga patient without catch growth impaired hrqol especially mental health domain impairment related height attained parameter related treatment rhgh selective involvement mental health domain suggests patient investigated neuro-cognitive psychiatric issue may affect hrqol adulthood qol-aghda questionnaire show significant correlation physical mental domain sf-36 although sensitivity detecting decline hrqol patient